BioSpace News Archive

There has been a lot of discussions this week about political alignment at the Council of the Federation, but we’re pleased to see that Premiers are agreeing on one of the most important issues facing this country: the state of our health care system.

Forty Seven, Inc., a clinical-stage, immuno-oncology company focused on developing therapies to activate macrophages in the fight against cancer, and Ono Pharmaceutical Co., Ltd. today announced an exclusive license agreement for the development, manufacture and commercialization of 5F9, Forty Seven’s monoclonal antibody against CD47.

The Asthma and Allergy Foundation of America addresses concerns regarding the Final Evidence Report assessing the clinical effectiveness and value of treatments for peanut allergy released by the Institute for Clinical and Economic Review (ICER) on July 10, 2019.

Tizona Therapeutics, Inc., a clinical stage, privately held immunotherapy company, today announced the appointment of Joyson Karakunnel, MD, MSc, FACP as Senior Vice President and Chief Medical Officer .

SOTIO and Cytune Pharma, members of the PPF Group, announce today the first dosing of cancer patients with SO-C101, a superagonist fusion protein of interleukin IL-15.

A new study conducted by researchers in Leicester and Nottingham has shown the potential for a new blood test to not only diagnose human tuberculosis (TB) but also identify those at most risk of developing the disease, according to findings published in medical journal Clinical Infectious Diseases.

Elicio Therapeutics, today announced that studies of its Amphiphile platform in combination with CAR-T therapy (AMP-CAR-T) have shown that activation of CAR-T cells in the lymphatic system gives massive CAR-T cell expansion, and significant functional improvements including enhanced CAR-T cell infiltration of solid tumors, increased anti-tumor cytolytic potential, and improved cytokine response.

Twenty-one physicians from Georgia Urology –the largest urology practice in the Southeast– rank among Castle Connolly’s Top Doctors.

President Donald J. Trump announced the recipients of the Presidential Early Career Award for Scientists and Engineers (PECASE).

Endologix, Inc., a developer and marketer of innovative treatments for aortic disorders, announced the grant of inducement equity awards to three newly hired employees.